Predicting Hypoxia in Brain Tumors from Multiparametric MRI

TL;DR

This study develops deep learning models to predict hypoxia in brain tumors using MRI scans, offering a cost-effective alternative to FMISO PET imaging with high accuracy demonstrated on a clinical dataset.

Contribution

The paper introduces a novel deep learning approach to predict FMISO PET hypoxia signals from MRI, improving accessibility and reducing costs in clinical hypoxia assessment.

Findings

Strong correlation between predicted and actual FMISO PET signals

PSNR score above 29.6 indicates high image quality

SSIM score greater than 0.94 demonstrates excellent structural similarity

Abstract

This research paper presents a novel approach to the prediction of hypoxia in brain tumors, using multi-parametric Magnetic Resonance Imaging (MRI). Hypoxia, a condition characterized by low oxygen levels, is a common feature of malignant brain tumors associated with poor prognosis. Fluoromisonidazole Positron Emission Tomography (FMISO PET) is a well-established method for detecting hypoxia in vivo, but it is expensive and not widely available. Our study proposes the use of MRI, a more accessible and cost-effective imaging modality, to predict FMISO PET signals. We investigate deep learning models (DL) trained on the ACRIN 6684 dataset, a resource that contains paired MRI and FMISO PET images from patients with brain tumors. Our trained models effectively learn the complex relationships between the MRI features and the corresponding FMISO PET signals, thereby enabling the prediction of hypoxia from MRI scans alone. The results show a strong correlation between the predicted and actual FMISO PET signals, with an overall PSNR score above 29.6 and a SSIM score greater than 0.94, confirming MRI as a promising option for hypoxia prediction in brain tumors. This approach could significantly improve the accessibility of hypoxia detection in clinical settings, with the potential for more timely and targeted treatments.